Drug maker Glenmark and Evestra Inc, a San Antonio-based biopharmaceutical research and development company with focus in women’s healthcare, have signed a licensing and commercialization agreement for development and marketing of a generic version of Merck & Co.’s NuvaRing, for the US market
Read More'We need to ensure that our workforce is healthier and disease free,' says Vishal Gondal, CEO and founder of GOQii
Read More'On part of Ministry of External affairs, we have asked all our chairs and missions to take a serious look to promote Ayush and Ayurveda,' says Minister VK Singh
Read MoreThe pharmaceuticals market expanded at a CAGR of 17.46 per cent during 2005-16, from $6 billion in 2005 to $36.7 billion in 2016
Read MoreSun's net profit for the October-December period fell to Rs 1,472 crore from Rs 1,545 crore a year earlier
Read MoreThe patent challenges could remove barriers to production and distribution of affordable generic versions of direct-acting antiviral medicines, which are currently sold at very high prices
Read MoreThe theme of the two-day conference was 'Clinical Research in India – Patients First & Research for Patients'
Read MoreDrugmaker Aurobindo Pharma said on Friday it was looking to set up a manufacturing facility for injectable products in the United States, days after President Donald Trump called on pharmaceutical companies to make more drugs locally
Read More